Abstract
Purpose of Review
Recent advancements in transcatheter valvular interventions have resulted in a growing demand for advanced cardiac imaging to help guide these procedures.
Recent Findings
Both echocardiography and multi-detector computed tomography have played essential roles in the maturation of transcatheter aortic valve replacement and are now building on these experiences and helping inform the nascent field of transcatheter mitral interventions.
Summary
Advanced imaging is essential to aid in the diagnosis and determination of the mechanism of mitral regurgitation. In addition, they are integral to annular sizing, determination of the suitability of patient anatomy for specific devices and increasingly important in the determination of the risk of left ventricular outflow tract obstruction and providing appropriate patient-specific fluoroscopic angulation in advance of the procedure.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368(9540):1005–11. https://doi.org/10.1016/S0140-6736(06)69208-8.
Iung B, Baron G, Butchart EG, Delahaye F, GohlkeBärwolf C, Levang OW, et al. A prospective survey of patients with valvular heart disease in Europe: the euro heart survey on Valvular heart disease. Eur Heart J. 2003;24(13):1231–43. https://doi.org/10.1016/S0195-668X(03)00201-X.
Mehta RH, Eagle KA, Coombs LP, Peterson ED, Edwards FH, Pagani FD, et al. Society of Thoracic Surgeons National Cardiac Registry. Influence of age on outcomes in patients undergoing mitral valve replacement. Ann Thorac Surg. 2002;74(5):1459–67. https://doi.org/10.1016/S0003-4975(02)03928-0.
Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al. ACC/AHA task force members. 2014 AHA/ ACC guideline for the Management of Patients with Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation. 2014;129(23):e521–643. https://doi.org/10.1161/CIR.0000000000000031.
Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597–607. https://doi.org/10.1056/NEJMoa1008232.
Acker MA, Parides MK, Perrault LP, Moskowitz AJ, Gelijns AC, Voisine P, et al. Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med. 2014;370(1):23–32. https://doi.org/10.1056/NEJMoa1312808.
Feldman T, Young A. Percutaneous approaches to valve repair for mitral regurgitation. J Am Coll Cardiol. 2014;63(20):2057–68. https://doi.org/10.1016/j.jacc.2014.01.039.
Herrmann HC, Maisano F. Transcatheter therapy of mitral regurgitation. Circulation. 2014;130(19):1712–22. https://doi.org/10.1161/CIRCULATIONAHA.114.009881.
Moat N, Duncan A, Lindsay AC, Quarto C, Blanke P, Leipsic J, et al. Transcatheter mitral valve replacement for the treatment of mitral regurgitation: in hospital outcomes of first-in-man experience with an apically tethered device. J Am Coll Cardiol. 2015;65(21):2352–3. https://doi.org/10.1016/j.jacc.2015.01.066.
Cheung A, Webb J, Verheye S, Moss R, Boone R, Leipsic J, et al. Short-term results of Transapical Transcatheter mitral valve implantation for mitral regurgitation. J Am Coll Cardiol. 2014;64(17):1814–9. https://doi.org/10.1016/j.jacc.2014.06.1208.
Bapat V, Buellesfeld L, Peterson MD, Hancock J, Reineke D, Buller C, et al. Transcatheter mitral valve implantation (TMVI) using the Edwards FORTIS device. EuroIntervention. 2014;10 Suppl U:U120–8. https://doi.org/10.4244/EIJV10SUA18.
Sondergaard L, Brooks M, Ihlemann N, Jonsson A, Holme S, Tang M et al. Transcatheter mitral valve implantation via transapical approach: an early experience. Eur J Cardiothorac Surg. 2015;48(6):837–7; discussion 877-8. https://doi.org/10.1093/ejcts/ezu546
Schoenhagen P, Numburi U, Halliburton SS. Three-dimensional imaging in the context of minimally invasive and transcatheter cardiovascular interventions using multi-detector computed tomography: from pre-operative planning to intra-operative guidance. Eur Heart J. 2010;31(22):2727–40. https://doi.org/10.1093/eurheartj/ehq302.
• Blanke P, Naoum C, Webb J, Dvir D, Hahn R, Grayburn P, et al. Multimodality imaging in the context of Transcatheter mitral valve replacement: establishing consensus among modalities and disciplines. JACC Cardiovasc Imaging. 2015;8(10):1191–208. https://doi.org/10.1016/j.jcmg.2015.08.004. This paper defines the evolving role of multimodality procedures in the guidance of TMVR.
Natarajan N, Patel P, Bartel T, Kapadia S, Navia J, Stewart W, et al. Peri-procedural imaging for transcatheter mitral valve replacement. Cardiovascular Diagnosis and Therapy. 2016;6(2):144–59. https://doi.org/10.21037/cdt.2016.02.04.
Van de Heyning CM, Magne J, Vrints CJ, Piérard L, Lancellotti P. The role of multi-imaging modality in primary mitral regurgitation. Eur Heart J Cardiovasc Imaging. 2012;13(2):139–51. https://doi.org/10.1093/ejechocard/jer257.
Alkadhi H, Wildermuth S, Bettex DA, Plass A, Baumert B, Leschka S, et al. Mitral regurgitation: quantification with 16-detector row CT—initial experience. Radiology. 2006;238:463.
Vural M, Ucar O, Celebi OO, Cicekcioglu H, Durmaz HA, Selvi NA, et al. Evaluation of effective regurgitant orifice area of mitral valvular regurgitation by multislice cardiac computed tomography. J Cardiol. 2010;56(2):236–9. https://doi.org/10.1016/j.jjcc.2010.06.001.
Shanks M, Delgado V, Ng AC, van der Kley F, Schuijf JD, Boersma E, et al. Mitral valve morphology assessment: three dimensional transesophageal echocardiography versus computed tomography. Ann Thorac Surg. 2010;90(6):1922–9. https://doi.org/10.1016/j.athoracsur.2010.06.116.
Guo YK, Yang ZG, Ning G, Rao L, Dong L, Pen Y, et al. Isolated mitral regurgitation: quantitative assessment with 64-section multidetector CT—comparison with MR imaging and echocardiography. Radiology. 2009;252(2):369–76. https://doi.org/10.1148/radiol.2522081714.
Killeen RP, Arnous S, Martos R, Abbara S, Quinn M, Dodd JD. Chronic mitral regurgitation detected on cardiac MDCT: differentiation between functional and valvular aetiologies. Eur Radiol. 2010;20(8):1886–95. https://doi.org/10.1007/s00330-010-1760-4.
Feuchtner GM, Alkadhi H, Karlo C, Sarwar A, Meier A, Dichtl W, et al. Cardiac CT angiography for the diagnosis of mitral valve prolapse: comparison with echocardiography. Radiology. 2010;254(2):374–83. https://doi.org/10.1148/radiol.2541090393.
Delgado V, Tops LF, Schuijf JD, de Roos A, Brugada J, Schalij MJ, et al. Assessment of mitral valve anatomy and geometry with multislice computed tomography. JACC Cardiovasc Imaging. 2009;2(5):556–65. https://doi.org/10.1016/j.jcmg.2008.12.025.
Beaudoin J, Thai WT, Wai B, Handschumacher M, Levine R, Truong QA. Assessment of mitral valve adaptation with gated cardiac computed tomorgraphy: validation with three-dimensionsal echocardiography and mechanistic insight to functional mitral regurgitaiton. Circ Cardiovascular Imaging. 2013;6(5):784–9. https://doi.org/10.1161/CIRCIMAGING.113.000561.
• Blanke P, Dvir D, Cheung A, Ye J, Levine R, Precious B, et al. A simplified D-shaped model of the mitral annulus to facilitate CT-based sizing before transcatheter mitral valve implantation. J Cardiovasc Comput Tomogr. 2014;8(6):459–67. https://doi.org/10.1016/j.jcct.2014.09.009. This paper introduced the concept of the D-shaped annulus.
Blanke P, Dvir D, Cheung A, Levine RA, Thompson C, Webb JG, et al. Mitral annular evaluation with computed tomography in the context of Transcatheter mitral valve implantation. JACC Cardiovasc Imaging. 2015;8(5):612–5. https://doi.org/10.1016/j.jcmg.2014.07.028.
Ormiston JA, Shah PM, Tei C, Wong M. Size and motion of the mitral valve annulus in man. I. A two-dimensional echocardiographic method and findings in normal subjects. Circulation. 1981;64(1):113–20. https://doi.org/10.1161/01.CIR.64.1.113.
Flachskampf FA, Chandra S, Gaddipatti A, Levine RA, Weyman AE, Ameling W, et al. Analysis of shape and motion of the mitral annulus in subjects with and without cardiomyopathy by echocardiographic 3-dimensional reconstruction. J Am Soc Echocardiogr. 2000;13(4):277–87. https://doi.org/10.1067/mje.2000.103878.
Mihaila S, Muraru D, Piasentini E, Miglioranza MH, Peluso D, Cucchini U, et al. Quantitative analysis of mitral annular geometry and function in healthy volunteers using transthoracic three-dimensional echocardiography. J Am Soc Echocardiogr. 2014;27(8):846–33. https://doi.org/10.1016/j.echo.2014.04.017.
Sonne C, Sugeng L, Watanabe N, Weinert L, Saito K, Tsukiji M, et al. Age and body surface area dependency of mitral valve and papillary apparatus parameters: assessment by real-time three-dimensional echocardiography. Eur J Echocardiogr. 2009;10:287–94.
Alkadhi H, Desbiolles L, Stolzmann P, Leschka S, Scheffel H, Plass A, et al. Mitral annular shape, size, and motion in normals and in patients with cardiomyopathy: evaluation with computed tomography. Investig Radiol. 2009;44(4):218–25. https://doi.org/10.1097/RLI.0b013e3181994a73.
Gordic S, Nguyen-Kim TD, Manka R, Sündermann S, Frauenfelder T, Maisano F, et al. Sizing the mitral annulus in healthy subjects and patients with mitral regurgitation: 2D versus 3D measurements from cardiac CT. Int J Cardiovasc Imaging. 2014;30(2):389–98. https://doi.org/10.1007/s10554-013-0341-4.
Naoum C, Leipsic J, Cheung A, Ye J, Bilbey N, Mak G, et al. Mitral annular dimensions and geometry in patients with functional mitral regurgitation and mitral valve prolapse: implications for transcatheter mitral valve implantation. JACC Cardiovasc Imaging. 2016;9(3):269–80. https://doi.org/10.1016/j.jcmg.2015.08.022.
Carmo P, Andrade MJ, Aguiar C, Rodrigues R, Gouveia R, Silva JA. Mitral annular disjunction in myxomatous mitral valve disease: a relevant abnormality recognizable by transthoracic echocardiography. Cardiovascular Ultrasound. 2010;8(1):53. https://doi.org/10.1186/1476-7120-8-53.
Hutchins GM, Moore GW, Skoog DK. The association of floppy mitral valve with disjunction of the mitral annulus fibrosus. N Engl J Med. 1986;314(9):535–40. https://doi.org/10.1056/NEJM198602273140902.
Savage DD, Garrison RJ, Castelli WP, McNamara PM, Anderson SJ. Prevalence of submitral (anular) calcium and its correlates in a general population-based sample (the Framingham study). Am J Cardiol. 1983;51(8):1375–8. https://doi.org/10.1016/0002-9149(83)90315-6.
Deluca G, Correale M, Ieva R, Del Salvatore B, Gramenzi S, Di Biase M. The incidence and clinical course of caseous calcification of the mitral annulus: a prospective echocardiographic study. J Am Soc Echocardiogr. 2008;21(7):828–33. https://doi.org/10.1016/j.echo.2007.12.004.
Plank F, Al-Hassan D, Nguyen G, Raju R, Wheeler M, Thompson C, et al. Caseous calcification of the mitral annulus. Cardiovasc Diagn Ther. 2013;3(2):E1–3. https://doi.org/10.3978/j.issn.2223-3652.2013.06.01.
Lutter G, Lozonschi L, Ebner A, Gallo S, Kall CM, Missov E, et al. First-in-human off-pump transcatheter mitral valve replacement. JACC Cardiovasc Interv. 2014;7(9):1077–8. https://doi.org/10.1016/j.jcin.2014.06.007.
•• Blanke P, Naoum C, Dvir D, Bapat V, Ong K, Muller D et al. Predicting LVOT Obstruction in Transcatheter Mitral Valve Implantation: Concept of the Neo-LVOT. JACC Cardiovasc Imaging. 2017;10(4):482–485. https://doi.org/10.1016/j.jcmg.2016.01.005. This manuscript introduced the concept of the Neo-LVOT which is being adopted as the anatomical measure relevant to risk assessment in TMVR.
Blanke P, Dvir D, Naoum C, Cheung A, Ye J, Thériault-Lauzier P, et al. Prediction of fluoroscopic angulation and coronary sinus location by CT in the context of transcatheter mitral valve implantation. J Cardiovasc Comput Tomogr. 2015;9(3):183–92. https://doi.org/10.1016/j.jcct.2015.02.007.
Dvir D, Webb JG, Bleiziffer S, Pasic M, Waksman R, Kodali S, et al. Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. JAMA. 2014;312(2):162–70. https://doi.org/10.1001/jama.2014.7246.
Cheung A, Webb JG, Barbanti M, Freeman M, Binder RK, Thompson C, et al. 5-year experience with transcatheter transapical mitral valve-in-valve implantation for bioprosthetic valve dysfunction. J Am Coll Cardiol. 2013;61(17):1759–66. https://doi.org/10.1016/j.jacc.2013.01.058.
• Guerrero M, Dvir D, Himbert D, Urena M, Eleid M, Wang DD, et al. Transcatheter mitral valve replacement in native mitral valve disease with severe mitral annular calcification: results from the first multicenter global registry. JACC Cardiovasc Interv. 2016;9(13):1361–71. https://doi.org/10.1016/j.jcin.2016.04.022. This is the first multicenter report discussing the valve in MAC procedure.
•• Pache G, Schoechlin S, Blanke P, Dorfs S, Jander N, Arepalli CD, et al. Early hypo-attenuated leaflet thickening in balloon-expandable transcatheter aortic heart valves. Eur Heart J. 2015;37(28):2263–71. https://doi.org/10.1093/eurheartj/ehv526. This important manuscript introduced the concept of HALT to the clinical and interventional cardiology community.
Yanagisawa R, Hayashida K, Yamada Y, Tanaka M, Fumiaki Y, Inohara T, et al. Incidence, predictors, and mid-term outcomes of possible leaflet thrombosis after TAVR. J Am Coll Cardiol Img. 2017;10(1):1–11.
Soon J, Pibarot P, Blanke P, Ohana M, Leipsic J. Multimodality Imaging For Planning And Follow-Up Of TAVR. Can J Cardiol. 2017;33(9):1110–1123. https://doi.org/10.1016/j.cjca.2017.03.024
Abbara S, Blanke P, Maroules CD, Cheezum M, Choi AD, Han BK, et al. SCCT guidelines for the performance and acquisition of coronary computed tomographic angiography: a report of the society of cardiovascular computed tomography guidelines committee: endorsed by the north American Society for Cardiovascular Imaging (NASCI). J Cardiovasc Comput Tomogr. 2016;10(6):435–49. https://doi.org/10.1016/j.jcct.2016.10.002.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Rominder Grover, Mickael Ohana, Chesnal Dey Arepalli, Stephanie L. Sellers, John Mooney, Shaw-Hua Kueh and Ung Kim declare that they have no conflict of interest.
Jonathon A. Leipsic is a consultant to Heartflow, Circle CVI, and Edwards Lifesciences. He provides Institutional Core Lab Support to Edwards Lifesciences, Neovasc, Tendyne, Ancora, Medtronic, and LASSO; and he has stock options in Heartflow, PI Cardia, and Circle CVI.
Philipp Blanke has received honoraria from HeartFlow, Edwards Lifesciences, Tendyne Holdings, and Circle Imaging. And he provides Institutional corelab services to: Edwards Lifesciences, Medtronic, Tendyne, and Neovasc.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Cardiac PET, CT, and MRI
Rights and permissions
About this article
Cite this article
Grover, R., Ohana, M., Arepalli, C.D. et al. Role of MDCT Imaging in Planning Mitral Valve Intervention. Curr Cardiol Rep 20, 16 (2018). https://doi.org/10.1007/s11886-018-0960-4
Published:
DOI: https://doi.org/10.1007/s11886-018-0960-4